Introduction 

Monkeypox, recently renamed Mpox by the World Health Organization, is a zoonotic disease that has captured global attention due to outbreaks beyond its usual endemic regions in West and Central Africa. With symptoms similar to smallpox but generally milder, Mpox is caused by the monkeypox virus, a member of the Orthopoxvirus genus. This article discusses the causes, symptoms, treatment, and prevention strategies to increase awareness and promote health safety around Mpox.

What Causes Monkeypox (Mpox)?

Mpox is caused by the monkeypox virus, which can infect humans through various modes of transmission. The virus originates in animals, particularly rodents and primates, which serve as natural hosts. Mpox is classified as a zoonotic virus, meaning it can be transmitted from animals to humans. Human-to-human transmission can also occur, which has driven recent outbreaks globally.

Modes of Transmission

• Animal-to-Human Transmission: Humans may contract the monkeypox virus through direct contact with infected animals, including bites, scratches, and handling contaminated animal products.

• Human-to-Human Transmission: Close contact with an infected person can spread Mpox. This can happen through respiratory droplets, direct contact with body fluids, or contact with materials contaminated with the virus (such as bedding).

• Fomite Transmission: Infected individuals can spread the virus to surfaces, making it possible for others to contract Mpox by touching those contaminated objects.

Symptoms of Monkeypox (Mpox)

Mpox symptoms usually appear between 7 to 14 days after exposure, but the incubation period can range from 5 to 21 days. The disease progresses through stages, starting with a prodromal phase where flu-like symptoms are common, followed by the development of a rash.

Key Symptoms Include:

• Fever: One of the first signs, Typically accompanied by chills, fever, sweating, and fatigue, resembling the symptoms of malaria.

• Headache and Muscle Aches: Common flu-like symptoms during the early phase.

• Lymphadenopathy (Swollen Lymph Nodes): This is a distinguishing feature of Mpox that sets it apart from smallpox.

• Rash: The characteristic Mpox rash begins on the face and then spreads to other body parts, including palms and soles. The rash progresses from macules (flat lesions) to papules (raised lesions), vesicles (fluid-filled blisters), and finally scabs, which eventually fall off.

Rash Phases

• Macules: Flat lesions.

• Papules: Raised bumps.

• Vesicles: Fluid-filled blisters.

• Pustules: Lesions filled with pus.

• Scabs: As lesions dry, they form scabs that eventually fall off.

The illness typically lasts for 2 to 4 weeks, with symptoms gradually resolving. However, in severe cases, particularly among immunocompromised individuals, symptoms may persist and complications can arise.

How Is Mpox Diagnosed?

Diagnosis involves both clinical examination and laboratory testing. Healthcare providers typically assess the rash, symptom history, and recent travel to regions where Mpox is endemic or an outbreak has occurred. Lab tests, particularly PCR (Polymerase Chain Reaction) tests, are conducted to confirm the presence of the monkeypox virus.

Treatment Options for Monkeypox (Mpox)

Currently, there is no specific treatment for Mpox, but the condition is usually self-limiting. Most people recover without medical intervention. However, supportive care and symptom management are essential.

1. Symptom Management: Fever reducers, pain relievers, and fluids can help alleviate symptoms.

2. Antiviral Medications: Some antivirals, such as Tecovirimat (TPOXX), are being evaluated and have shown promise in managing severe cases.

3. Vaccination: The JYNNEOS vaccine (also known as Imvamune or Imvanex) has been approved for preventing Mpox. It’s recommended for individuals exposed to the virus or those at high risk.

Prevention Strategies for Monkeypox (Mpox)

Prevention remains the most effective approach to combating Mpox. Here are key preventive measures:

1. Avoid Contact with Potentially Infected Animals

Since Mpox is zoonotic, reducing exposure to animals that may carry the virus, such as rodents and primates, is crucial. Avoid handling wild animals and ensure pets do not come into contact with animals that could be carriers.

2. Practice Good Hygiene

Hand hygiene is critical. Wash hands frequently with soap and water, especially after coming into contact with potentially infected people, animals, or surfaces. Alcohol-based hand sanitizers are also effective.

3. Isolate Infected Individuals

Isolation of confirmed or suspected Mpox cases helps prevent the virus from spreading. Individuals diagnosed with Mpox should avoid close contact with others until they have fully recovered and their rash has healed.

4. Use Personal Protective Equipment (PPE)

Healthcare providers and caregivers should wear PPE, including gloves, gowns, and masks when treating infected individuals. This helps prevent the spread of the virus through droplets and contact with bodily fluids.

5. Vaccination for High-Risk Individuals

The JYNNEOS vaccine, previously used against smallpox, has shown efficacy in preventing Mpox. It is especially recommended for healthcare workers, laboratory personnel, and individuals at high risk of exposure.

Myths and Misconceptions about Mpox

Due to its resemblance to smallpox and the COVID-19 pandemic, Mpox has been the subject of various myths and misconceptions. Here are a few clarifications:

• Mpox is not the same as smallpox: While they belong to the same virus family, Mpox is generally less severe and has a lower mortality rate.

• Mpox is not as contagious as COVID-19: Mpox requires closer and more prolonged contact for transmission, unlike COVID-19, which spreads primarily through airborne particles.

Vaccines are available and effective: Though vaccines against smallpox were developed long ago, they remain effective in preventing Mpox.

Frequently Asked Questions about Mpox

1. Can Mpox Be Prevented with the Smallpox Vaccine?

Yes, the smallpox vaccine, particularly the JYNNEOS vaccine, offers protection against Mpox. However, it’s primarily recommended for high-risk individuals or those with potential exposure.

2. How Severe is Mpox Compared to Smallpox?

Mpox is less severe than smallpox, with a much lower mortality rate. Most people recover from Mpox without complications, though severe cases can occur, especially in those with weakened immune systems.

3. Is There a Cure for Mpox?

Currently, there is no cure for Mpox. However, antiviral medications like Tecovirimat may help manage severe cases. Most patients recover through supportive care alone.

Conclusion

Mpox is a viral disease that has recently spread beyond its usual regions due to increased human-to-human transmission. Understanding the causes, symptoms, treatment, and prevention measures is vital to managing outbreaks effectively and protecting public health. Preventive practices, vaccination for at-risk individuals, and prompt medical care for those infected are essential to reducing the spread of Mpox.